European monitoring centre for drugs and drug addiction (EMCDDA) (2016) EU drug market report. http://www.emcdda.europa.eu/system/files/publications/2373/TD0216072ENN.pdf. Accessed 17 Jul 2016
United Nations Office on Drugs and Crime (UNODC) (2012) World Drug Report 2012, Vienna. https://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_web_small.pdf. Accessed 17 Jul 2016
United Nations Office on Drugs and Crime (UNODC) (2013) World Drug Report 2013, Vienna. https://reliefweb.int/int/sites/reliefweb.int/files/resources/World%20Drug%20Report%202013.pdf. Accessed 17 Jul 2016
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2012) New drugs in Europe. http://www.emcdda.europa.eu/attachments.cfm/att_212366_EN_EMCDDA-Europol%202012%20Annual%Report_final.pdf. Accessed 28 May 2016
Moosmann B, King LA, Auwärter V (2015) Designer benzodiazepines: a new challenge. World Psychiatry 14:248
Article
PubMed
PubMed Central
Google Scholar
Mattila MAK, Larni HM (1980) Flunitrazepam: a review of its pharmacological properties and therapeutic use. Drugs 20:353–374
CAS
Article
PubMed
Google Scholar
Woods JH, Winger G (1997) Abuse liability of flunitrazepam. J Clin Psychopharmacol 17:1S–57S
CAS
Article
PubMed
Google Scholar
KFx (2015) Drug facts. Newer unregulated drugs. Research chemical briefings, pp 1–41. http://www.kfx.org.uk/drug_facts/drugs_images_and_pdfs/researchchemicals_4.2015.pdf#search=‘drug+facts.+newer+unregulated+drugs%2C+2015’. Accessed 28 Jul 2016
Wikipedia (2016) Desmethylflunitrazepam. http://en.wikipedia.org/wiki/Desmethylflunitrazepam. Accessed 9 Jun 2016
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2016) Formal notification of 5-(2-fluorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (fonazepam) by Sweden as a new psychoactive substance under the terms of Council Decision 2005/387/JHA. EU Early Warning System Formal Notification RCS ID EU-EWS-RCS-FN-2016-0029. https://ednd.emcdda.europa.eu/html.cfm/index7246EN.html?SUB_ID=608&detail. Accessed 28 Jul 2016
Wikipedia (2016) Nifoxipam. https://en.wikipedia.org/wiki/Nifoxipam. Accessed 12 Jul 2016
EDND (2016) Nifoxipam. https://ednd.emcdda.europa.eu/html.cfm/index7246EN.html?SUB_ID=479&detail. Accessed 11 Jul 2016
Baselt RC (2004) Disposition of toxic drugs and chemicals in man, 7th edn. Biomedical Publications, Foster City, pp 465–468
Google Scholar
Busker RW, Beijersbergen van Henegowen GMJ, Kwee BMC, Winkens JHM (1987) Photobinding of flunitrazepam and its major photo-decomposition product N-desmethylflunitrazepam. Int J Pharm 36:113–120
CAS
Article
Google Scholar
Pubchem (2015) 2H-1,4-Benzodiazepin-2-one, 5-(2-fluorophenyl)-1,3-dihydro-7-nitro-. https://pubchem.ncbi.nlm.nih.gov/substance/250115239#section=Depositor-Supplied-Synonyms. Accessed 12 Jun 2016
Bulgalupum (2016) Fonazepam. https://www.bulgalupum.com/products/Fonazepam. Accessed 9 Jun 2016
Psychonautwiki (2016) Nifoxipam. https://www.psychonautwiki.org/wiki/Nifoxipam. Accessed 9 Jul 2016
drugs-forum.com/forum/showwiki.php?title = Nifoxipam. Accessed 12 Jul 2016
Sternbach LH, Fryer RI, Keller O, Metlesics W, Sach G, Steiger N (1963) Quinazolines and 1,4-benzodiazepines. X. Nitro-substituted 5-phenyl-1,4-benzodiazepine derivatives. J Med Chem 6:261–265
CAS
Article
PubMed
Google Scholar
Wendt G (1976) Schicksal des Hypnotikum Flunitrazepam in menschlichen Organismus. In: Hügin HG, Gemperle M (eds) Bisherigerfahrungen mit “Rohypnol” (flunitrazepam) in der Anästhesiologie und Intensivtherapie. Roche Editions, Basel, pp 27–38
Google Scholar
Mandrioli R, Mercolini L, Raggi MA (2008) Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab 9:827–844
CAS
Article
PubMed
Google Scholar
Erowid (2016) Erowid experience vaults report ID: 105406. https://www.erowid.org/experiences/exp.php?ID=105406. Accessed 16 Jul 2016
Bluelight (2016) Nifoxipam/1 mg—first time—melting sedative warmth. http://bluelight.org/vb/archieve/index.php/t-720084.html. Accessed 12 Jul 2016
Drugs-form (2014) Six hours on meclonazepam and nifoxipam in the end (timeline). https://drugs-forum.com/forum/showthread.php?t=266079. Accessed 12 Jul 2016
Coller JK, Somogyi AA, Bochner F (1999) Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4. Xenobiotica 29:973–986
CAS
Article
PubMed
Google Scholar
Hesse LM, Venkatakrishnan K, von Molthe LL, Shader RI, Greenblatt DJ (2001) CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. Drug Metab Dispos 29:133–140
CAS
PubMed
Google Scholar
Kilicarslan T, Haining R, Rettie AE, Busto U, Tyndale RF, Sellers EM (2001) Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4. Drug Metab Dispos 29:460–465
CAS
PubMed
Google Scholar
Gafni I, Busto UE, Tyndale RF, Kaplan HL, Sellers EM (2003) The role of cytochrome P450 2C19 activity in flunitrazepam metabolism in vivo. J Clin Psychopharmacol 23:169–175
CAS
Article
PubMed
Google Scholar
Hallifax D, Galetin A, Houston JB (2008) Prediction of metabolic clearance using fresh human hepatocytes: comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines. Xenobiotica 38:353–367
CAS
Article
PubMed
Google Scholar
Meyer MR, Bergstrand MP, Helander A, Beck O (2016) Identification of main human metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high resolution mass spectrometry for drug testing analysis. Anal Bioanal Chem 408:3571–3591
CAS
Article
PubMed
Google Scholar
Goodchild CS (1993) GABA receptors and benzodiazepines. Br J Anaesth 71:127–133
CAS
Article
PubMed
Google Scholar
Robertson M, Raymon L (2001) Rohypnol and other benzodiazepines. In: LeBeau MA, Mozayani A (eds) Drug facilitated sexual assault. Academic Press, London, pp 89–105
Google Scholar
Haefely W (1984) Benzodiazepine interactions with GABA receptors. Neurosci Lett 47:201–206
Article
Google Scholar
Xiang P, Shen M, Drummer OH (2015) Review: drug concentrations in hair and their relevance in drug facilitated crimes. J Forensic Leg Med 36:126–135
Article
PubMed
Google Scholar
Maddalena DJ, Johnston GAR (1995) Prediction of receptor properties and binding affinity of ligands to benzodiazepine/GABAA receptors using artificial neural networks. J Med Chem 38:715–724
CAS
Article
PubMed
Google Scholar
So SS, Karplus M (1996) Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors. J Med Chem 39:5246–5256
CAS
Article
PubMed
Google Scholar
http://drugs.tripsit.me/nifoxipam. Accessed 12 Jul 2016
McLean MJ, MacDonald RL (1988) Benzodiazepines, but not beta carbolines, limit high frequency repetitive firing of action potentials of spinal cold neurons in cell culture. J Pharmacol Exp Ther 244:789–795
CAS
PubMed
Google Scholar
Mignée C, Garnier R, Conso F, Efthymiou ML, Fournier E (1980) Acute overdose with flunitrazepam. Therapie 35:581–589
PubMed
Google Scholar
Bramness JG, Skurtveit S, Mørland J (2006) Flunitrazepam: psychomotor impairement, agitation and paradoxical reactions. Forensic Sci Int 159:83–91
CAS
Article
PubMed
Google Scholar
Lann MA, Molina DK (2009) A fatal case of benzodiazepine withdrawal. Am J Forensic Med Pathol 30:177–179
Article
PubMed
Google Scholar
Kales A, Scharf MB, Kales JD, Soldatos CR (1979) Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. JAMA–J Am Med Assoc 241:1692–1695
CAS
Article
Google Scholar
Vermeeren A (2004) Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 18:297–328
CAS
Article
PubMed
Google Scholar
Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Mørland J (2008) Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 9:812–822
Article
Google Scholar
Paton C (2002) Benzodiazepines and disinhibition: a review. Psychiatr Bull 26:460–462
Article
Google Scholar
Saïas T, Gallarda T (2008) Réactions d’agressivité sous benzodiazepines: une revue de la literature. Encephale 34:330–336
Article
PubMed
Google Scholar
Bond JA (1998) Drug-induced behavioral disinhibition: incidence, mechanisms and therapeutic implications. CNS Drugs 9:41–57
CAS
Article
Google Scholar
Drummer OH (2002) Benzodiazepines—effects on human performance and behavior. Forensic Sci Rev 14:1–14
CAS
PubMed
Google Scholar
Europol (2016) Reporting form on new psychoactive drug. 5-(2-fluorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (fonazepam), Germany. 13.01.2016. Hague
Europol (2016) Reporting form on new psychoactive drug. 5-(2-fluorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (fonazepam), Sweden. 19.04.2016. Hague
Europol (2015) Reporting form on new psychoactive drug. 5-(2-fluorophenyl)-3-hydroxy-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (nifoxipam), Sweden. 07.01.2015. Hague
Europol (2015) Reporting form on new psychoactive drug. 5-(2-fluorophenyl)-3-hydroxy-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (nifoxipam), Finland. 18.02.2015. Hague
Europol (2015) Reporting form on new psychoactive drug. 5-(2-fluorophenyl)-3-hydroxy-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (nifoxipam), Norway. 28.10.2015. Hague
Europol (2015) Reporting form on new psychoactive drug. 5-(2-fluorophenyl)-3-hydroxy-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (nifoxipam). Slovenia. 29.07.2015. Hague
Europol (2015) Reporting form on new psychoactive drug. 5-(2-fluorophenyl)-3-hydroxy-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (nifoxipam), Denmark. 30.06.2015. Hague
Europol (2015) Reporting form on new psychoactive drug. 5-(2-fluorophenyl)-3-hydroxy-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (nifoxipam), France. 19.11.2015. Hague
Europol (2015) Reporting form on new psychoactive drug. 5-(2-fluorophenyl)-3-hydroxy-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one (nifoxipam), France. 26.10.2015. Hague
Lader M (1980) The present status of benzodiazepines and psychiatry and medicine. Drug Res 30:910–913
CAS
Google Scholar
Ashton H (2002) Benzodiazepines: how they work and how to withdraw, “The Ashton Manual”. http://www.benzo.org.uk/manual/bzcha03.htm. Accessed 30 Jul 2016
Salamone SJ, Honasoge S, Brenner C, McNally AJ, Passarelli J, Goc-Szkutnicka K (1997) Flunitrazepam excretion patterns using the Abuscreen OnTrak and OnLine immunoassays: comparison with GC-MS. J Anal Toxicol 21:341–345
CAS
Article
PubMed
Google Scholar
Bergstrand MP, Helander A, Hansson T, Beck O (2016) Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunoassays. Drug Test Anal. doi:10.1002/dta.2003
Google Scholar
de Silva JAF, Bekersky I, Puglisi CV, Brooks MA, Weinfeld RE (1976) Determination of 1,4-benzodiazepines and -diazepin-2-ones in blood by electron-capture gas-liquid chromatography. Anal Chem 48:10–19
Article
PubMed
Google Scholar
Faber DB, Kok RM, Rempt-Van Dijk EM (1977) Quantitative gas chromatographic analysis of flunitrazepam in human serum with electron-capture detection. J Chromatogr 133:319–326
CAS
Article
PubMed
Google Scholar
Drouet-Coassolo C, Iliadis A, Coassolo P, Antoni M, Cano JP (1990) Pharmacokinetics of flunitrazepam following single dose oral administration in liver disease patients compared with healthy volunteers. Fundam Clin Pharmacol 4:643–651
CAS
Article
PubMed
Google Scholar
Coller JK, Somogyi AA, Bochner F (1998) Quantification of flunitrazepam’s oxidative metabolites, 3-hydroxyflunitrazepam and desmethylflunitrazepam, in hepatic microsomal incubations by high-performance liquid chromatography. J Chromatogr B 719:87–92
CAS
Article
Google Scholar
Nguyen H, Nau DR (2000) Rapid method for the solid phase extraction and GC–MS analysis of flunitrazepam and its major metabolites in urine. J Anal Toxicol 24:37–45
CAS
Article
PubMed
Google Scholar
Borrey D, Mayer E, Lambert W, Van Peteghem C, De Leenheer AP (2001) Simultaneous determination of fifteen low-dosed benzodiazepines in human urine by solid-phase extraction and gas chromatography–mass spectrometry. J Chromatogr B 765:187–197
CAS
Article
Google Scholar
Pirnay S, Bouchonnet S, Hervé F, Libong D, Milan N, d’Athis P, Baud F, Ricordel I (2004) Development and validation of a gas chromatography-mass spectrometry method for the simultaneous determination of buprenorphine, flunitrazepam and their metabolites in rat plasma: application to the pharmacokinetic study. J Chromatogr B 807:335–342
CAS
Article
Google Scholar
Pirnay S, Megarbane B, Declèves X, Risède P, Borron SW, Bouchonnet S, Bérangère P, Debray M, Milan N, Duarte T, Ricordel I, Baud FJ (2008) Buprenorphine alters desmethylflunitrazepam disposition and flunitrazepam toxicity in rats. Toxicol Sci 106:64–73
CAS
Article
PubMed
Google Scholar
Bogusz MJ, Maier R-D, Krüger K-D, Früchtnicht W (1998) Determination of flunitrazepam and its metabolites in blood by high-performance liquid chromatography–atmospheric pressure chemical ionization mass spectrometry. J Chromatogr B 713:361–3369
CAS
Article
Google Scholar
Dussy FE, Hamberg C, Briellmann TA (2006) Quantification of benzodiazepines in whole blood and serum. Int J Legal Med 120:323–330
Article
PubMed
Google Scholar
Kollroser M, Schober C (2002) Simultaneous analysis of flunitrazepam and its major metabolites in human plasma by high performance liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 25:1173–1182
Article
Google Scholar
Joudril N, Bessard J, Vincent F, Eysseric H, Bessard G (2003) Automated solid-phase extraction and liquid-chromatography–electrospray ionization–mass spectrometry for the determination of flunitrazepam and its metabolites in human urine and plasma. J Chromatogr B 788:207–219
Article
Google Scholar
Forsman M, Nyström I, Roman M, Berglund L, Ahlner J, Kronstrand R (2009) Urinary detection times and extraction patterns of flunitrazepam and its metabolites after a single oral dose. J Anal Toxicol 33:491–501
CAS
Article
PubMed
Google Scholar
Verplaetse R, Cuypers E, Tytgat J (2012) The evaluation of the applicability of a high pH mobile phase in ultrahigh performance liquid chromatography tandem mass spectrometry analysis of benzodiazepines and benzodiazepine-like hypnotics in urine and blood. J Chromatogr A 1249:147–154
CAS
Article
PubMed
Google Scholar
Jeong Y-D, Kim MK, Suh SI, In MK, Paeng K-J (2015) Rapid determination of benzodiazepines, zolpidem and their metabolites in urine using direct injection liquid chromatography–tandem mass spectrometry. Forensic Sci Int 257:84–92
CAS
Article
PubMed
Google Scholar
Berthault F, Kintz P, Mangin R (1996) Simultaneous high-performance liquid chromatographic analysis of flunitrazepam and four metabolites in serum. J Chromatogr B 685:383–387
CAS
Article
Google Scholar
El Mahjoub A, Staub C (2001) High-performance liquid chromatography determination of flunitrazepam and its metabolites in plasma by use of column switching technique: comparison of two extraction columns. J Chromatogr B 754:271–283
Article
Google Scholar
He W, Parissis N (1997) Simultaneous determination of flunitrazepam and its metabolites in plasma and urine by HPLC/DAD after solid phase extraction. J Pharm Biomed Anal 16:707–715
CAS
Article
PubMed
Google Scholar
Huang C-W, Jen H-P, Wang R-D, Hsieh Y-Z (2006) Sweeping technique combined with micellar electrokinetic chromatography for the simultaneous determination of flunitrazepam and its major metabolites. J Chromatogr A 1110:240–244
CAS
Article
PubMed
Google Scholar
Wikipedia (2016) Controlled Drugs and Substances Act. http://en.wikipedia.org/wiki/Controlled_Drugs_and_Subtances_Act#Schedule _IV. Accessed 9 Jun 2016
Legislation.gv.uk. (2016) Psychoactive Substances Act. http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted. Accessed 9 Jul 2016